$ cat ./records/gates-foundation-funds-oxitec-cattle-tick-biocontrol-feasibility--2021.txt
Gates Foundation Funds Oxitec Cattle Tick Biocontrol Feasibility Research
[RECORD.TXT] · cat --full
The Bill & Melinda Gates Foundation awarded a $1.283 million, 14-month feasibility grant to Oxitec to evaluate whether self-limiting insect technology could control the Asian blue cattle tick (Rhipicephalus microplus). The tick causes an estimated $22 billion in annual livestock losses worldwide and transmits deadly babesiosis and anaplasmosis. Oxitec partnered with animal health firm Clinglobal to produce modified male ticks whose female offspring die before adulthood, offering a non-pesticide, species-specific tool for farmers in sub-Saharan Africa, Latin America, and South Asia.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Awards Oxitec $4.85 Million to Advance Self-Limiting Cattle Tick Program
Next →
Cascade Investment Makes Gates the Largest Private Farmland Owner in the United States
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.